Genetic factors are well-recognized to play an important role in the pathogenesis of Alzheimer's disease (AD). This is best unerstood for the genes causing early onset familial AD (EOAD), namely APP, PS1 and PS2. A single genetic factor influencing age of onset in late onset AD (LOAD) is also recognized, namely ApoE. Nevertheless, there still exist large gaps in our understanding of the genetic aspects of AD including additional genetic factors impacting age of onset, penetrance and phenotypic expression of both EAOD and LOAD. Furthermore, it is clear that many other types of hereditary dementia overlap clinically, pathologically and molecularly with AD, as well as being important in their own right. The purpose of the UW ADRC Genetics Core is to provide a unique resource of family material and genotyping information to qualified investigators to advance our understanding of genetic factors in AD and other dementing illnesses.
The Specific Aims are:
Specific Aim 1 : To recruit, characterize, sample and follow families with Alzheimer's disease and other forms of dementia. Phenotypic data and samples from these families will be made available to investigators in the U W ADRC and other appropriate scientists at the University of Washington and other institutions.
Specific Aim 2 : Provide serum/plasma/DNA banking for studies of AD and other dementias.
Specific Aim 3 : Provide genotyping and mutational analysis for AD and dementia studies including (a) apolipoprotein (APOE) genotyping, (b) APOE haplotyping for 20 SNP sites including promoter polymorphisms and (c) mutation screening for known dementia genes including presenilins 1 and 2 (PSEN1,PSEN2), the prion gene (PRNP), MAPT (gene for tau), a-synuclein (ASN), parkin and DJ-1.
Specific Aim 4 : Provide genotyping and mutational anlysis for new dementia genes and polymorphic sites identified other AD investigators. Materials and information from this Core will be made available to collaborators within the UW ADRC, the UW Health Sciences Complex and all other relevant investigators in the US and worldwide.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005136-25
Application #
7622116
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
25
Fiscal Year
2008
Total Cost
$190,541
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kunji, Khalid; Ullah, Ehsan; Nato Jr, Alejandro Q et al. (2018) GIGI-Quick: a fast approach to impute missing genotypes in genome-wide association family data. Bioinformatics 34:1591-1593
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Taylor, Laura M; McMillan, Pamela J; Liachko, Nicole F et al. (2018) Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener 13:7

Showing the most recent 10 out of 753 publications